Drug intelligence / Profile preview

ibuprofen + opioid medication

Development stage
Unknown
Lead developer
Allergan
Modality
Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Ibuprofen + opioid medication refers to fixed-dose oral combinations of the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen with an opioid analgesic such as oxycodone or hydrocodone. These combinations are used for short-term management of moderate to severe acute pain when other pain medicines are insufficient or not tolerated. Ibuprofen acts by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis involved in inflammation and pain signaling. The opioid component (e.g., oxycodone or hydrocodone) acts primarily as a mu-opioid receptor agonist in the central nervous system to alter perception of and response to pain. These products provide additive analgesic effects from both components but carry risks associated with each class—such as gastrointestinal toxicity and cardiovascular risk from NSAIDs, plus dependence potential and respiratory depression from opioids. They are typically prescribed for short durations (usually less than 7–10 days) due to these risks[1][2][5][9].

Brand names
CombunoxIbudoneReprexainVicoprofenCodofenIbucodone
Other names
ibuprofen and oxycodone combinationibuprofen and hydrocodone combination
02

Targets

MOR (Mu opioid receptor)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on ibuprofen + opioid medication.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen + opioid medication.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call